Your session is about to expire
← Back to Search
Accelerated Theta-Burst Stimulation for Obsessive-Compulsive Disorder
Study Summary
This trial will test if an accelerated schedule of theta-burst stimulation using a TMS device can help people with OCD who haven't responded to other treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have an eating disorder.I have been diagnosed with bipolar disorder recently.My OCD symptoms started after I turned 30.I have been taking the same SRI medication for at least 8 weeks and plan to continue during the study.I have undergone Electroconvulsive Therapy.I understand and can agree to the study's procedures and risks.I have tried or refused standard OCD treatments like SRI or therapy.I have been diagnosed with OCD and it's moderately severe.I have had an implanted device or psychosurgery.I am starting or have recently started Cognitive Behavioral Therapy.I have a history of brain-related health issues or a close relative with seizures.I have not tested positive for illegal drugs, except for prescribed meds or coca tea.My depression is not severe based on my last HDRS-17 score.I can handle the procedures involved in the study.You are physically able to undergo all necessary tests and procedures for the study.You are currently feeling extremely sad or having thoughts of hurting yourself.
- Group 1: right OFC
- Group 2: bilateral DMPFC
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this trial accommodate those aged fifty or above?
"This medical trial is open to individuals 18-80 years of age. There are 23 studies for minors and 67 separate trials for seniors over 65."
Is it feasible to take part in this medical trial?
"The clinical trial is recruiting 180 individuals with a DSM-5 diagnosis of obsessive compulsive disorder (OCD) who have attained the age of majority but are below 80 years old. In order to qualify, they must display moderate severity in OCD as determined by their YBOCS score and demonstrate stable use of SRI medication for 8 weeks prior to joining the study. The candidates also need to have unsuccessfully gone through an APA approved first line treatment or rejected these treatments due to individual reasons, be able to provide informed consent, tolerate all required procedures, and pass screening forms at Stanford CNI without any contraindications."
Does this clinical trial still have participants available for enrollment?
"According to clinicaltrials.gov, recruitment for this medical study is still open. It was initially advertised on 15th January 2021 and the most recent update occurred during 20th December of the same year."
What are the desired results of this clinical investigation?
"The primary outcome measure of this clinical trial, assessed after the duration of treatment, is the percentage change in Yale-Brown Obsessive-Compulsive Scale (YBOCS). Secondary outcomes encompass changes from baseline functional connectivity to 1 month post-treatment via resting state fMRI between subcallosal cingulate and default mode network as well as within it. Furthermore, there will be a Percentage Change in Patient Health Questionnaire 9 (PHQ9) scores with higher scores representing greater severity, and finally a comparison between baseline and each day's treatment regarding functional connectivities."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger